You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Cdk7 antibody [MO1.1] (ab9516)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Cdk7 antibody [MO1.1]
See all Cdk7 products (11) ...

Description

Mouse monoclonal [MO1.1] to Cdk7

Specificity

This antibody is specific to human CAK (CDK-activating kinase), a 40 kDa protein.

Tested applications

Flow Cyt, ICC/IF, IP, WB, IHC-Frmore details

Cross reactivity

Reacts with

Mouse, Human

Immunogen

Recombinant 221 amino acid fragment of the C-terminus of human p40M015.

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Purity

Tissue culture supernatant

Clonality

Monoclonal

Clone number

MO1.1

Myeloma

unknown

Isotype

IgG2b

Light chain type

unknown

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cdk7 antibody [MO1.1] (ab9516)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cdk7 antibody [MO1.1] (ab9516) image (enlarge)

  • Flow Cytometry-Anti-Cdk7 antibody [MO1.1](ab9516)Flow Cytometry-Anti-Cdk7 antibody [MO1.1](ab9516) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Anti-Cdk7 antibody [MO1.1] (ab9516)Immunocytochemistry/ Immunofluorescence - Anti-Cdk7 antibody [MO1.1] (ab9516) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab9516 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between two subsequent phases in the cell cycle. CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex, a serine-threonine kinase. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Involved in cell cycle control and in RNA transcription by RNA polymerase II. Its expression and activity are constant throughout the cell cycle.

Tissue specificity

Ubiquitous.

Sequence similarities

Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.
Contains 1 protein kinase domain.

Post-translational
modifications

Phosphorylation of Ser-164 during mitosis inactivates the enzyme.
Phosphorylation of Thr-170 is required for activity.

Cellular localization

Nucleus.

Target information above from: UniProt accessionP50613 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • 39 kDa protein kinase antibody
  • CAK antibody
  • CAK1 antibody
  • Cdk activating kinase antibody
  • CDK-activating kinase antibody
  • cdk7 antibody
  • CDK7_HUMAN antibody
  • CDKN7 antibody
  • Cell division protein kinase 7 antibody
  • Cyclin dependent kinase 7 antibody
  • Cyclin-dependent kinase 7 antibody
  • Homolog of Xenopus MO15 Cdk activating kinase antibody
  • Kinase subunit of CAK antibody
  • MO15 antibody
  • P39 Mo15 antibody
  • p39MO15 antibody
  • Serine threonine kinase Stk1 antibody
  • Serine/threonine protein kinase 1 antibody
  • Serine/threonine protein kinase MO15 antibody
  • STK1 antibody
  • TFIIH basal transcription factor complex kinase subunit antibody
see all

Anti-Cdk7 antibody [MO1.1] images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cdk7 antibody [MO1.1] (ab9516)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cdk7 antibody [MO1.1] (ab9516)

ab9516 staining human cervical cancer cells by IHC-P.

  Flow Cytometry-Anti-Cdk7 antibody [MO1.1](ab9516)

Flow Cytometry-Anti-Cdk7 antibody [MO1.1](ab9516)

Overlay histogram showing HeLa cells stained with ab9516 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab59516, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2µg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed.

  Immunocytochemistry/ Immunofluorescence - Anti-Cdk7 antibody [MO1.1] (ab9516)

Immunocytochemistry/ Immunofluorescence - Anti-Cdk7 antibody [MO1.1] (ab9516)

ICC/IF image of ab9516 stained MCF7 cells. The cells were 4% formaldehyde (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab9516, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96879 Dylight 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-Cdk7 antibody [MO1.1] (ab9516)

This product has been referenced in:

  • Lu WTet al. The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms. Cell Cycle 10: (2011). WB; Human.Read more (PubMed: 21926477) »
  • Ito Set al. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol Cell 26:231-43 (2007). WB; Human.Read more (PubMed: 17466625) »

See all 2 publications for this product

Publishing research using ab9516? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"